IP Library Granted Patent US 8,795,718
Granted Patent B2
US 8,795,718 · App. 12/125,096 · Granted Aug 5, 2014

Functional nano-layered hemostatic material/device

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,795,718
App. No.
12/125,096
Granted
Aug 5, 2014
Kind
B2
Abstract

The present invention utilizes a nano-coating of an oxide such as silica, a silicate or another effective oxide on a surface to accelerate blood clotting in mammalian animals. The hemostatic layer has a thickness that is effective for the hemostasis, yet can be made thin enough to result in a resorbable film which can either be applied to a biocompatible or resorbable device that can be used in surgical applications as well as in topical applications such as trauma.

Claims (10)

1. A hemostatic article consisting of:

a) a fibrous substrate consisting of one or more fibers, said fibers being selected from the group consisting of lyocell fibers, rayon fibers, aramid fibers, acrylic fibers, polyester fibers, polyolefin fibers, poly(p-phenylene-2,6-benzobisoxazole) fibers, liquid crystal polymer fibers and combinations thereof; and

b) a uniform film coating having a thickness of 5 nm to 100 nm on a surface of the fibrous substrate,

said 5 nm to 100 nm uniform film coating consisting of a hemostatically effective, hydrophilic oxide, wherein the hemostatically effective, hydrophilic oxide coating consists of SiO 2 , a silicate, aluminosilicate, GeO 2 , silicogermanate, germanate, AlPO 4 , a metal or main group element aluminophosphate, Fe 2 O 3 , or a mixture thereof, and

wherein the uniform film coating on the fibrous substrate is formed by chemical vapor deposition, plasma-enhanced chemical vapor deposition or atomic layer deposition.

2. The hemostatic article of claim 1 wherein the substrate consists of a non-woven fibrous substrate.

3. The hemostatic article of claim 1 wherein the substrate consists of a woven fibrous substrate.

4. The hemostatic article of claim 1 wherein the hemostatically effective, hydrophilic oxide consists of an aluminosilicate.

5. The hemostatic article of claim 1 wherein said uniform film coating consists of a mixture of silica and aluminosilicate.

6. The hemostatic article of claim 1 wherein the hemostatically effective, hydrophilic oxide consists of SiO 2 .

Assignments (5)
NUNC PRO TUNC ASSIGNMENT Recorded Apr 12, 2026
From: HONEYWELL INTERNATIONAL INC.
To: SOLSTICE ADVANCED MATERIALS US, INC.
Reel/Frame 074344/0157 →
SECURITY INTEREST Recorded Jan 12, 2026
From: SOLSTICE ADVANCED MATERIALS US, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 074569/0260 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 5, 2014
From: WILCHER, STEVEN A.
To: HONEYWELL INTERNATIONAL INC.
Reel/Frame 032819/0988 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 4, 2009
From: UOP LLC
To: HONEYWELL INTERNATIONAL INC.
Reel/Frame 022341/0981 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 22, 2008
From: BEDARD, ROBERT L
To: UOP LLC
Reel/Frame 020982/0763 →